• There are no suggestions because the search field is empty.
Literature Monitoring Services  Vigilance - QbD Group

Literature Monitoring Services

Enhance regulatory compliance with expert literature monitoring

Staying ahead of safety signals and medical information requires continuous monitoring of scientific literature. At QbD Group, our comprehensive Literature Monitoring Services ensure your product safety processes, applications, and equipment align with regulatory requirements. By systematically tracking relevant publications, we help you stay compliant, informed, and confident in your pharmacovigilance strategy.

What is literature monitoring?

Literature monitoring involves the systematic review of scientific journals, publications, and medical databases to identify safety information relevant to medicinal products or medical devices. This process plays a critical role in pharmacovigilance, enabling the timely detection of adverse events, safety signals, and new medical insights. Key aspects of literature monitoring:

  • Global and local monitoring: Tracking publications from international and region-specific sources.
  • Adverse event detection: Identifying and reporting safety signals or adverse drug reactions (ADRs).
  • Medical information solutions: Extracting relevant clinical data to support product safety and regulatory submissions.
  • Regulatory compliance: Ensuring alignment with EMA, FDA, and other global pharmacovigilance requirements.
  • Customized reporting: Delivering tailored literature reports based on your product portfolio and markets.

Discover why literature monitoring is essential

Literature Monitoring Services - Vigilance - QbD Group

Why is literature monitoring essential?

Scientific literature is a key source of safety data and medical insights. Effective monitoring ensures:

  • Regulatory adherence: Meet mandatory reporting requirements for global health authorities.

  • Early risk detection: Identify safety signals and adverse events promptly to protect patient safety.

  • Informed decision-making: Leverage clinical data to improve pharmacovigilance strategies.

  • Compliance confidence: Stay ahead of updates and requirements with accurate, timely monitoring.

  • Enhanced safety assurance: Strengthen your product’s safety profile with continuous oversight.

 

Discover how we can support you

QbD Group’s Literature Monitoring Services provide end-to-end solutions to elevate your pharmacovigilance and compliance processes:

Global and regional coverage

Global and regional coverage

Monitoring scientific publications, including international journals, local databases, and grey literature.

Adverse event identification

Adverse event identification

Detecting and reporting ADRs and safety signals to meet regulatory requirements.

Tailored search strategies

Tailored search strategies

Developing customized search terms to align with your products and processes.

Structured reporting

Structured reporting

Providing clear, actionable literature reports to integrate into your pharmacovigilance systems.

Inspection readiness

Inspection readiness

Preparing your organization for audits and inspections to ensure compliance.

Medical insights extraction

Medical insights extraction

Capturing valuable clinical information to support safety and regulatory submissions.

Literature Monitoring Services - Vigilance - QbD Group (1)

Why partner with QbD Group?

Partnering with QbD Group for Literature Monitoring Services ensures:

  • Regulatory expertise: Decades of experience delivering compliant pharmacovigilance solutions.

  • Global reach: Comprehensive monitoring of international and regional literature sources.

  • Customized solutions: Tailored search strategies and reports based on your specific needs.

  • Timely reporting: Accurate and prompt identification of safety information to meet reporting timelines.

  • Trusted results: A proven track record of enhancing safety and regulatory compliance for clients worldwide.

doc-mask

Related content

preview_image
Blog

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

It shouldn’t be a surprise that today, “Near-Patient Testing (NPT)” and...
preview_image
Blog

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

In the European regulatory landscape, conducting performance studies for in...
preview_image
Blog

How to define your Clinical Performance Strategy?

1. Start with a clear intended purpose A strong clinical...
preview_image
Blog

The Holy Grail: Achieving Inspection Readiness

In a previous blog post, we talked about the various activities...
contact-mail

Get in touch

Need comprehensive literature monitoring to enhance your product safety?

QbD Group delivers tailored literature monitoring solutions to ensure compliance, detect safety signals, and provide actionable medical insights. Contact us today to see how we can help.

Vigilance_Get in touch